2Wang GP, Guan YS, Jin XR , et al. Development of novel 5-fluorouracil carrier erythrocyte with pharmacokinetics and potent antitumor activity in mice bearing malignant ascites [ J ]. Gastroenterol Hepatol,2010,25 (5) :985.
5Garin MI,Lopez RM,Sanz S,et al. Erythrocytes as carriers for recombinant human erythropoietin[J]. Pharm Res,1996,13(6):869-874.
6Sanz S,Lizano C,Luque J,et al. In vitro and in vivo study of glutamate dehydrogenase encapsulated into mouse erythrocytes by a hypotonic dialysis procedure[J]. Life Sci,1999,65(26):2781-2789.
7Kravtzoff R,Ropars C,Laguerre M,et al. Erythrocytes as carriers for L-asparaginase. Methodological and mouse in-vivo studies[J]. J Pharm Pharmacol,1990,42(7):473-476.
8O'Byrne KJ,Steward WP. The promise of improved drug delivery[J]. Clin Sci (London),1999, 96(2):127-128.
9Jain S,Jain NK. Preparation,characterization and pharmaceutical potential of engineered erythrocytes[J]. Pharmazie,1998,53(1):5-14.
10Tajerzadeh H,Hamidi M. Evaluation of hypotonic preswelling method for encapsulation of enalaprilat in intact human erythrocytes[J]. Drug Dev Ind Pharm,2000,26(12):1247-1257.
9Muzykantov VR. Drag delivery by red blood cells: vas- cular carriers designed by mother nature[J]. Expert Opin Drug Deliv, 2010, 7(4): 403-427.
10Yann G, Francoise H, Robertf F, et al. International semi- nar on the red blood cells as vehicles for drugs[J]. Ex- pert Opin Biol Ther, 2012, 12(1): 127-133.
